Stille AB
Research Stille AB (STIL) on Bullrun: valuation model: 8.1% undervalued, market cap SEK 2.22B, P/E 35.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSTIL
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Valuation signal8.1% undervalued
- Market capSEK 2.22B
- P/E35.8
- Financial periodQ1 2026
- RevenueSEK 179.07M
- Net incomeSEK 20.92M
- Free cash flowSEK 22.46M
- Gross margin49.1%
Valuation Snapshot
Bullrun's latest valuation model marks Stille AB as 8.1% undervalued; latest market cap is SEK 2.22B; P/E is 35.8.
About Stille AB
Stille AB develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps;
Frequently asked questions
Is Stille AB overvalued or undervalued?
Bullrun's valuation model currently marks Stille AB as 8.1% undervalued.
What is Stille AB's market cap?
Stille AB's market capitalization is SEK 2.22B.
What is Stille AB's P/E ratio?
Stille AB's price-to-earnings (P/E) ratio is 35.8.
What does Stille AB do?
Stille AB develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments.